Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics ProfileAI Aided Target Engagement Research Advancing Development of ...

Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical ...

NEW YORK (WPIX) – A popular antidepressant is being recalled because it may contain elevated levels of a cancer-causing substance, according to the U.S. Food and Drug Administration. Thousands of ...

New MSK research provides structural insights into how cancer cells thwart targeted RAS therapies; uncovers promising combination therapies for a rare childhood brain tumor; uses organoids to provide ...

CHICAGO – Revolution Medicines’ experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume activities they previously ...

In the first of a six-part Health Matters wellness series on cancer in Hong Kong, Emily Hung looks into how the city takes on its leading cause of death while maintaining one of the lowest mortality ...

Former U.S. Attorney General Pam Bondi was diagnosed with and treated for thyroid cancer after leaving the Department of Justice in early 2026. Rating: True (About this rating?) Rumors that ousted U.S ...

SANTA FE — Ben Sasse may be dying, but he’s still spreading a message of hope and humor. The former U.S. senator from Nebraska and University of Florida president spoke to 120 graduates at St. John’s ...

SINGAPORE - Debbie Ong En Yu, now 12, was diagnosed with a form of bone cancer when she was in kindergarten, but that has not stopped her from volunteering to help others. The Tao Nan School pupil, ...

Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...

Scientists at UBC Okanagan have uncovered how plants produce mitraphylline, a rare natural compound with promising anti cancer potential. The team identified two enzymes that work together to build ...